Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | VP, Chief Accounting Officer | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,629 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 1,500 · Balance 20,629 F1: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 21:02 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 1,500 | $5.33 | $7,995.00 |
DisclosureSEC source: 0002079955-26-000003 · ownership.xml · nonDerivative · entry 1 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,629 F1 · shares: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 3,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · derivative · entry 13 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,002 Underlying: Common Stock · 3,001 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F9 · derivative.exercise_date: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date. F9 · derivative.expiration_date: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · derivative · entry 12 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,749 Underlying: Common Stock · 2,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F8 · derivative.exercise_date: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. F8 · derivative.expiration_date: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · derivative · entry 11 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,755 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: The restriced stock units were fully vested on March 1, 2026. F7 · derivative.expiration_date: The restriced stock units were fully vested on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,155 | $6.10 | $7,045.50 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 9 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,129 F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 8 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,058 | $6.10 | $6,453.80 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 7 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,283 F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 6 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 520 | $6.10 | $3,172.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 5 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,591 F4 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on February 28, 2023 and vested on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 1,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 4 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,111 F3 · shares: The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on February 28, 2023. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 675 | $6.10 | $4,117.50 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 3 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,760 F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 2 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 1,500 | $6.10 | $9,150.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · nonDerivative · entry 1 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,680 F1 · shares: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 17:00 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088630 · ownership.xml · derivative · entry 10 Wright Mary E · CIK 0002079955 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.